Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 2/20 | 0.41 |
| ▸ | FEN1 | P39748 | 2/20 | 0.41 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14658995 | 0.75 | ALOX5AP (0.38) | ALOX5APFEN1F2RL1DGAT1 | |
| SCHEMBL19602414 | 0.75 | CSNK2A1 (0.44) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL26648940 | 0.75 | ALOX5AP (0.41) | ALOX5APFEN1DGAT1 | |
| SCHEMBL5514200 | 0.75 | ALOX5AP (0.46) | ALOX5APFEN1DGAT1ALDH1A1 | |
| SCHEMBL8377141 | 0.74 | HTT (0.49) | CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL23580858 | 0.74 | NPC1 (0.41) | ALOX5APFEN1CYP4F2CYP4A11 | |
| SCHEMBL4701131 | 0.74 | ALOX5AP (0.42) | ALOX5APFEN1DGAT1 | |
| SCHEMBL30811273 | 0.74 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL25417461 | 0.74 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL25417856 | 0.71 | ATR (0.37) | ALOX5APFEN1F2RL1DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008088-A1 | COMPOUNDS AS TRK INHIBITORS AND/OR RET INHIBITORS AND USE THEREOF | 河南迈英诺医药科技有限公司 | 2024-01-11 | — | — | WO | disclosed |